Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins
Author(s) -
Megan R. Edwards,
Gai Liu,
Chad E. Mire,
Suhas Sureshchandra,
Priya Luthra,
Benjamin Yen,
Reed S. Shabman,
Daisy W. Leung,
Ilhem Messaoudi,
Thomas W. Geisbert,
Gaya K. Amarasinghe,
Christopher F. Basler
Publication year - 2016
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2016.01.049
Subject(s) - marburg virus , ebola virus , mda5 , interferon , biology , virology , innate immune system , rna , downregulation and upregulation , ebolavirus , rig i , interferon regulatory factors , immune system , interferon type i , immunology , virus , rna interference , gene , genetics
Suppression of innate immune responses during filoviral infection contributes to disease severity. Ebola (EBOV) and Marburg (MARV) viruses each encode a VP35 protein that suppresses RIG-I-like receptor signaling and interferon-α/β (IFN-α/β) production by several mechanisms, including direct binding to double stranded RNA (dsRNA). Here, we demonstrate that in cell culture, MARV infection results in a greater upregulation of IFN responses as compared to EBOV infection. This correlates with differences in the efficiencies by which EBOV and MARV VP35s antagonize RIG-I signaling. Furthermore, structural and biochemical studies suggest that differential recognition of RNA elements by the respective VP35 C-terminal IFN inhibitory domain (IID) rather than affinity for RNA by the respective VP35s is critical for this observation. Our studies reveal functional differences in EBOV versus MARV VP35 RNA binding that result in unexpected differences in the host response to deadly viral pathogens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom